Aaron Cox joined Galapagos as Chief Financial Officer and member of the Executive Committee on July 7, 2025. Aaron is a seasoned financial and strategic executive with nearly two decades of leadership experience across biotechnology, capital markets, and M&A/corporate development. Most recently, he served as Executive Vice President and Chief Financial Officer at Horizon Therapeutics plc, where he played a pivotal role in the company’s $28 billion acquisition by Amgen. In this role, he led global corporate finance, investor relations, IT, and real estate functions, and was instrumental in driving the transformation of Horizon into a fully integrated global biopharmaceutical company. Prior to his role as Horizon’s CFO, Aaron served as Horizon’s Head of Corporate Development and Chief of Staff to the CEO, supporting capital markets strategy, M&A execution and business development. His earlier career spans senior investment banking roles at BMO Capital Markets, JMP Securities and Stout Risius Ross Advisors. Aaron holds an MBA with High Honors from the University of Chicago Booth School of Business and a Bachelor’s degree in Finance from the University of Notre Dame, graduating Magna Cum Laude.
